Hôpital Pierre Rouquès - Les Bluets.
Paris, 75012, France
NCT Number: NCT07499453
The main aim of this study is to evaluate the impact and identify potential indications for sequential double embryo transfer (SEQ-ET) in couples undergoing assisted reproductive technology (ART). The study will compare live birth rates (LBR) between patients receiving SEQ-ET and those receiving standard double embryo transfer (DET), while assessing safety outcomes and potential indications, including endometrial immune under-activation. Each SEQ-ET case will be matched with a DET control based on age, transfer attempt rank, and ART technique. We hypothesize that SEQ-ET may enhance implantation in couples with previous ART failures without increasing the risk of complications, potentially through localized maternal-endometrial immune communication initiated by the initially transferred cleavage-stage embryos.
Looking for future studies?
Notify Me20 year–42 year
Female
Observational
Paris, 75012, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From first embryo transfer to delivery (up to approximately 9 months).
LBR defined as delivery of a viable infant beyond 24 weeks of gestation, assessed after the first fresh or frozen blastocyst transfer.
Time frame: 6-8 weeks after embryo transfer.
Clinical pregnancy confirmed by ultrasound visualization of a gestational sac.
Time frame: Up to 24 weeks of gestation.
Pregnancy loss before 24 weeks of gestation among clinical pregnancies.
Time frame: 6-8 weeks after embryo transfer.
Number of gestational sacs per number of embryos transferred.
Time frame: Up to 9 months
Percentage of multiple pregnancies regardless of whether one or two day-2/3 are transferred before the day-5 embryo are transferred.
Hopital Pierre Rouques - Les Bluets
Other
A CASE-CONTROL OBSERVATIONAL STUDY ON THE IMPACT OF A SEQUENTIAL DOUBLE EMBRYO TRANSFER POLICY ON LIVE BIRTH RATES IN COUPLES UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY.
Acronym: SEQ-ET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details